FdaApplication
BLA 125350
Identifiers
- fda_app_no: BLA125350
Properties
| Property | Value |
|---|---|
| applicant_name | CSL Behring AG |
| application_type | BLA |
| approval_date | 2010-03-04 |
Products (8)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HIZENTRA | — | 2G/10ML | Injection |
| HIZENTRA | — | 1G/5ML | Injection |
| HIZENTRA | — | 4G/20ML | Injection |
| HIZENTRA | — | 2G/10ML | Injection |
| HIZENTRA | — | 10G/50ML | Injection |
| HIZENTRA | — | 10G/50ML | Injection |
| HIZENTRA | — | 4G/20ML | Injection |
| HIZENTRA | — | 1G/5ML | Injection |
8 products